These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10422568)

  • 1. [Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors].
    Shinohara M; Tomita M; Ohira S; Nishimura A
    Hokkaido Igaku Zasshi; 1999 May; 74(3):249-56. PubMed ID: 10422568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.
    Sève P; Billotey C; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2007 Jan; 109(2):292-9. PubMed ID: 17167760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of unknown occult primary tumors using positron emission tomography.
    Kole AC; Nieweg OE; Pruim J; Hoekstra HJ; Koops HS; Roodenburg JL; Vaalburg W; Vermey A
    Cancer; 1998 Mar; 82(6):1160-6. PubMed ID: 9506364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
    Rusthoven KE; Koshy M; Paulino AC
    Cancer; 2004 Dec; 101(11):2641-9. PubMed ID: 15517576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET detection of unknown primary tumors.
    Bohuslavizki KH; Klutmann S; Kröger S; Sonnemann U; Buchert R; Werner JA; Mester J; Clausen M
    J Nucl Med; 2000 May; 41(5):816-22. PubMed ID: 10809197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
    Barghouth G; Allaoua M; Goerres GW
    Rev Med Suisse Romande; 2000 Jun; 120(6):535-42. PubMed ID: 11014099
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
    Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
    Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
    Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
    Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
    Dede F; Ajoedi ND; Ansari SM; Jana S; Heiba SI; Abdel-Dayem HM
    Clin Nucl Med; 2001 May; 26(5):396-9. PubMed ID: 11317017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature.
    Dong MJ; Zhao K; Lin XT; Zhao J; Ruan LX; Liu ZF
    Nucl Med Commun; 2008 Sep; 29(9):791-802. PubMed ID: 18677207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
    Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
    Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
    AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
    Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F-FDG whole-body positron-emission tomography (PET) in patients with unknown primary tumors].
    Matheja P; Schober O
    Strahlenther Onkol; 2000 Mar; 176(3):151-2. PubMed ID: 10742838
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
    Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of positron emission tomography in occult primary head and neck cancers.
    Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
    Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.